MedX Health Corp
MDXHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.17 | 0.18 | -0.05 |
| FCF Yield | -818.20% | -26.28% | -56.28% | -33.17% |
| EV / EBITDA | -3.17 | -7.87 | -2.58 | -3.55 |
| Quality | ||||
| ROIC | 152.58% | 233.13% | 185.67% | 434.67% |
| Gross Margin | 39.66% | 40.70% | 46.99% | 51.40% |
| Cash Conversion Ratio | 0.69 | 0.75 | 0.55 | 0.85 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.38% | -6.78% | -1.24% | -13.17% |
| Free Cash Flow Growth | 26.63% | -22.18% | 38.22% | -55.55% |
| Safety | ||||
| Net Debt / EBITDA | -3.04 | -2.40 | -1.27 | -0.54 |
| Interest Coverage | -1.71 | -1.41 | -3.05 | -5.87 |
| Efficiency | ||||
| Inventory Turnover | 0.78 | 0.80 | 0.72 | 0.74 |
| Cash Conversion Cycle | 268.15 | -305.04 | -288.85 | -167.33 |